Figures that speak volumes
Over the past 2 years, Belgian pharmaceutical exports have risen by an impressive 70%, representing almost one-fifth of the country’s total exports. The local pharma industry trades its products not just within the EU, but also far beyond. Its main EU export markets are Germany, Italy, France, Spain and the Netherlands, while the US, the UK, China, Switzerland and Canada are its main customers outside of the EU.
What’s more, the sector channeled over EUR 1.5 billion into R&D activities in 2021. To put this figure into perspective, that’s about 40% of all private R&D investments in Belgium, a share that’s twice as much as the European average.